Dataset from A Phase 1/2 Multi-center, Open-label Study of Ponatinib in Japanese Patients With Chronic Myeloid Leukemia (CML) Who Have Failed Dasatinib or Nilotinib or Ph+ Acute Lymphoblastic Leukemia (ALL) Who Have Failed Prior Tyrosine Kinase Inhibitors (TKIs)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009653
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety and efficacy of ponatinib in Japanese
patients with chronic myeloid leukemia (CML) who have experienced failure of dasatinib or
nilotinib or with Ph+ acute lymphoblastic leukemia (ALL) following failure of prior tyrosine
kinase inhibitors (TKIs).
创建时间：
2024-11-26
